Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands

BMC Immunology

Volumn 10, Issue , 2009, Pages

  Grossmann, Claudius ^a   Tenbusch, Matthias ^a   Nchinda, Godwin ^b   Temchura, Vladimir ^a   Nabi, Ghulam ^a   Stone, Geoffrey W ^c   Kornbluth, Richard S ^d   Überla, Klaus ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD40 LIGAND; CELL ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; DNA VACCINE; GAG PROTEIN; IMMUNOLOGICAL ADJUVANT; PLASMID VECTOR; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR; CELL SURFACE RECEPTOR; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; DEC 205 RECEPTOR; DEC-205 RECEPTOR; HYBRID PROTEIN; LECTIN; LEUKOCYTE ANTIGEN; LIGAND; OLIGODEOXYRIBONUCLEOTIDE; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DNA IMMUNIZATION; DRUG EFFICACY; FEMALE; GENETIC ENGINEERING; IMMUNE RESPONSE; MOUSE; NONHUMAN; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG EFFECT; GENE VECTOR; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; GENE PRODUCTS, GAG; GENETIC VECTORS; HIV; LECTINS, C-TYPE; LIGANDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; POLY I-C; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; TOLL-LIKE RECEPTORS; VACCINES, DNA;

EID: 69349101739     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-10-43     Document Type: Article

References (32)

1. Steinman RM Banchereau J Taking dendritic cells into medicine Nature 2007, 449:419-426. 10.1038/nature06175 17898760
2. Hawiger D Inaba K Dorsett Y Guo M Mahnke K Rivera M Ravetch JV Steinman RM Nussenzweig MC Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo J Exp Med 2001, 194:769-779. 10.1084/jem.194.6.769 2195961 11560993
3. Bonifaz L Bonnyay D Mahnke K Rivera M Nussenzweig MC Steinman RM Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance J Exp Med 2002, 196:1627-1638. 10.1084/jem.20021598 2196060 12486105
4. Mahnke K Guo M Lee S Sepulveda H Swain SL Nussenzweig M Steinman RM The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments J Cell Biol 2000, 151:673-684. 10.1083/jcb.151.3.673 2185598 11062267
5. Mahnke K Qian Y Knop J Enk AH Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells Blood 2003, 101:4862-4869. 10.1182/blood-2002-10-3229 12543858
6. Kretschmer K Apostolou I Hawiger D Khazaie K Nussenzweig MC von BH Inducing and expanding regulatory T cell populations by foreign antigen Nat Immunol 2005, 6:1219-1227. 10.1038/ni1265 16244650
7. Hawiger D Masilamani RF Bettelli E Kuchroo VK Nussenzweig MC Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo Immunity 2004, 20:695-705. 10.1016/j.immuni.2004.05.002 15189735
8. Bonifaz LC Bonnyay DP Charalambous A Darguste DI Fujii S Soares H Brimnes MK Moltedo B Moran TM Steinman RM In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination J Exp Med 2004, 199:815-824. 10.1084/jem.20032220 2212731 15024047
9. Trumpfheller C Caskey M Nchinda G Longhi MP Mizenina O Huang Y Schlesinger SJ Colonna M Steinman RM The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine Proc Natl Acad Sci USA 2008, 105:2574-2579. 10.1073/pnas.0711976105 2268178 18256187
10. Trumpfheller C Finke JS Lopez CB Moran TM Moltedo B Soares H Huang Y Schlesinger SJ Park CG Nussenzweig MC Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine J Exp Med 2006, 203:607-617. 10.1084/jem.20052005 2118242 16505141
11. Nchinda G Kuroiwa J Oks M Trumpfheller C Park CG Huang Y Hannaman D Schlesinger SJ Mizenina O Nussenzweig MC et al The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells J Clin Invest 2008, 118:1427-1436. 10.1172/JCI34224 2263146 18324335
12. Barouch DH Rational design of gene-based vaccines J Pathol 2006, 208:283-289. 10.1002/path.1874 16362986
13. Guimaraes-Walker A Mackie N McCormack S Hanke T Schmidt C Gilmour J Barin B McMichael A Weber J Legg K Babiker A Hayes P Gotch F Smith C Dally L Dorrell L Cebere I Kay R Winstone N Moore S Goonetilleke N Fast P IAVI-006 Study Group Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers Vaccine 2008, 26(51):6671-7. 10.1016/j.vaccine.2008.09.016 18812202
14. McCormack S Stohr W Barber T Bart PA Harari A Moog C Ciuffreda D Cellerai C Cowen M Gamboni R et al EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone Vaccine 2008, 26:3162-3174. 10.1016/j.vaccine.2008.02.072 18502003
15. Harari A Bart PA Stohr W Tapia G Garcia M Medjitna-Rais E Burnet S Cellerai C Erlwein O Barber T et al An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses J Exp Med 2008, 205:63-77. 10.1084/jem.20071331 2234371 18195071
16. Tenbusch M Kuate S Tippler B Gerlach N Schimmer S Dittmer U Uberla K Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity BMC Immunol 2008, 9:13. 10.1186/1471-2172-9-13 2324072 18405363
17. Kuate S Stefanou D Hoffmann D Wildner O Uberla K Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses J Gene Med 2004, 6:1197-1205. 10.1002/ jgm.623 15459964
18. Stahl-Hennig C Kuate S Franz M Suh YS Stoiber H Sauermann U Tenner-Racz K Norley S Park KS Sung YC Steinman R Racz P Uberla K Atraumatic oral spray immunization with replication-deficient viral vector vaccines J Virol 2007, 81:13180-13190. 10.1128/JVI.01400-07 2169087 17898066
19. Stone GW Barzee S Snarsky V Kee K Spina CA Yu XF Kornbluth RS Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines J Virol 2006, 80:1762-1772. 10.1128/ JVI.80.4.1762-1772.2006 1367159 16439533
20. Betts MR Brenchley JM Price DA De Rosa SC Douek DC Roederer M Koup RA Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation J Immunol Methods 2003, 281:65-78. 10.1016/S0022-1759(03)00265-5 14580882
21. Robinson HL Amara RR T cell vaccines for microbial infections Nat Med 2005, 11:S25-S32. 10.1038/nm1212 15812486
22. Williams MA Tyznik AJ Bevan MJ Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells Nature 2006, 441:890-893. 10.1038/nature04790 16778891
23. Kanzler H Barrat FJ Hessel EM Coffman RL Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat Med 2007, 13:552-559. 10.1038/nm1589 17479101
24. Andrejeva J Childs KS Young DF Carlos TS Stock N Goodbourn S Randall RE The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter Proc Natl Acad Sci USA 2004, 101:17264-17269. 10.1073/pnas.0407639101 535396 15563593
25. Kawai T Akira S Antiviral signaling through pattern recognition receptors J Biochem 2007, 141:137-145. 10.1093/jb/mvm032 17190786
26. Seder RA Darrah PA Roederer M T-cell quality in memory and protection: implications for vaccine design Nat Rev Immunol 2008, 8:247-258. 10.1038/ nri2274 18323851
27. Barouch DH Rational design of gene-based vaccines J Pathol 2006, 208:283-289. 10.1002/path.1874 16362986
28. Klempa B Kruger DH Auste B Stanko M Krawczyk A Nickel KF Uberla K Stang A A Novel Cardiotropic Murine Adenovirus Representing a Distinct Species of Mastadenoviruses J Virol 2009, 83(11):5749-59. 10.1128/JVI.02281-08 19297486
29. Liu J Kjeken R Mathiesen I Barouch DH Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation J Virol 2008, 82:5643-5649. 10.1128/JVI.02564-07 2395223 18353952
30. Napolitani G Rinaldi A Bertoni F Sallusto F Lanzavecchia A Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells Nat Immunol 2005, 6:769-776. 10.1038/ni1223 15995707
31. Zheng R Cohen PA Paustian CA Johnson TD Lee WT Shu S Koski GK Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12 Cancer Res 2008, 68:4045-4049. 10.1158/ 0008-5472.CAN-07-6669 18519662
32. Zhu Q Egelston C Vivekanandhan A Uematsu S Akira S Klinman DM Belyakov IM Berzofsky JA Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines Proc Natl Acad Sci USA 2008, 105:16260-16265. 10.1073/ pnas.0805325105 2570973 18845682